Diabetic neuropathy
- PMID: 16461471
- PMCID: PMC2596705
- DOI: 10.1136/pgmj.2005.036137
Diabetic neuropathy
Abstract
Diabetic neuropathy (DN) refers to symptoms and signs of neuropathy in a patient with diabetes in whom other causes of neuropathy have been excluded. Distal symmetrical neuropathy is the commonest accounting for 75% DN. Asymmetrical neuropathies may involve cranial nerves, thoracic or limb nerves; are of acute onset resulting from ischaemic infarction of vasa nervosa. Asymmetric neuropathies in diabetic patients should be investigated for entrapment neuropathy. Diabetic amyotrophy, initially considered to result from metabolic changes, and later ischaemia, is now attributed to immunological changes. For diagnosis of DN, symptoms, signs, quantitative sensory testing, nerve conduction study, and autonomic testing are used; and two of these five are recommended for clinical diagnosis. Management of DN includes control of hyperglycaemia, other cardiovascular risk factors; alpha lipoic acid and L carnitine. For neuropathic pain, analgesics, non-steroidal anti-inflammatory drugs, antidepressants, and anticonvulsants are recommended. The treatment of autonomic neuropathy is symptomatic.
Conflict of interest statement
Conflicts of interest: none declared.
References
-
- Pickup J, Wilham G. Epidemiology of diabetes. In: Guikshank K, ed. Textbook of diabetes. New York: Blackwell Science, 1991
-
- Bajaj M, Banerji M A. Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian Indian epidemic. Curr Diab Rep 20044213–218. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
